Cleared Special

K180326 - icobrain

K180326 is the FDA 510(k) clearance for icobrain by Icometrix. It is a Class 2 Radiology device (product code LLZ) cleared through the Special 510(k) pathway after a 30-day FDA review.

K180326 · Icometrix · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2018
Decision
30d
Days
Class 2
Risk

K180326 is an FDA 510(k) clearance for the icobrain. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Icometrix (Leuven, BE). The FDA issued a Cleared decision on March 8, 2018 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Icometrix devices

Submission Details

510(k) Number K180326 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2018
Decision Date March 08, 2018
Days to Decision 30 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1094
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K180326.
Quantib Brain
K173939 · Quantib B.V. · Mar 2018
BrightMatter Plan 1.6.0
K180394 · Synaptive Medical, Inc. · Mar 2018
iQMR
K173605 · Medic Vision - Imaging Solutions, Ltd. · Mar 2018
ProBx Software
K173312 · Harmonus, Inc. · Mar 2018
CereMetrix Silver
K173145 · Ceremetrix Corp · Feb 2018
DM-Density
K170540 · Densitas, Inc. · Feb 2018